TickerFactsScreenerDevelopers

Burning Rock Biotech Ltd (BNR)

↓ Download CSV

CIK 0001792267 · Nasdaq · Services-Medical Laboratories

  • Sector Services

In fiscal 2025, Burning Rock Biotech Ltd reported revenue of 539.57M CNY, up 4.6% from the prior year. The company ran a net loss, with a net margin of -10.3% and a gross margin of 74.7%. It held 820.38M CNY in total assets against 285.11M CNY in total liabilities.

Key ratios (FY2025)

74.7%
Gross margin
-10.2%
Operating margin
-10.3%
Net margin
-10.3%
Return on equity
+4.6%
Revenue growth (YoY)
Metric (FY)202520242023202220212020201920182017
Revenue539.57M CNY515.82M CNY537.43M CNY563.24M CNY507.86M CNY429.90M CNY381.68M CNY208.87M CNY—
Cost of Revenue136.65M CNY153.42M CNY174.21M CNY183.20M CNY143.72M CNY115.98M CNY108.34M CNY73.81M CNY—
Gross Profit402.91M CNY362.40M CNY363.23M CNY380.04M CNY364.15M CNY313.92M CNY273.33M CNY135.06M CNY—
Operating Income-54.84M CNY-357.56M CNY-669.32M CNY-980.41M CNY-797.06M CNY-412.40M CNY-169.09M CNY-161.40M CNY—
Net Income-55.35M CNY-346.63M CNY-653.69M CNY-971.23M CNY-796.70M CNY-407.24M CNY-169.16M CNY-177.50M CNY—
Total Assets820.38M CNY885.30M CNY1.04B CNY1.59B CNY2.28B CNY2.66B CNY847.56M CNY——
Total Liabilities285.11M CNY304.48M CNY271.59M CNY429.13M CNY433.28M CNY242.02M CNY212.02M CNY——
Shareholders' Equity535.26M CNY580.83M CNY768.41M CNY1.16B CNY1.85B CNY2.42B CNY-891.49M CNY-603.46M CNY-372.16M CNY
Cash & Equivalents478.39M CNY519.85M CNY615.10M CNY905.45M CNY1.43B CNY1.90B CNY94.23M CNY93.34M CNY—
Operating Cash Flow-28.44M CNY-92.26M CNY-255.78M CNY-456.81M CNY-477.89M CNY-73.54M CNY-228.04M CNY-148.78M CNY—
Capital Expenditures5.25M CNY5.42M CNY8.10M CNY62.03M CNY204.33M CNY60.29M CNY42.97M CNY23.19M CNY—
Shares Outstanding—————025.03M——